DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

DAIC

MAY 13, 2024

milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc.announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. I am hopeful that Heart Rhythm Society’s conference will reflect this.” electrophysiology labs.

Heart Rhythm 101

Heart Rhythm Innovation Electrophysiology Technology 101

DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

DAIC

MAY 13, 2024

Innovative Health, Inc. electrophysiology labs, and will be participating in the Heart Rhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc. I am hopeful that Heart Rhythm Society’s conference will reflect this.”

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

DAIC

MAY 30, 2024

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

Technology 105

Technology Heart Rhythm Hospital Cardiac Arrest 105

DAIC

JULY 24, 2024

"Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. FDA 510(k) clearance and European CE Mark approval for its innovative products. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs). The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

JANUARY 24, 2024

This sub-study of the National Institutes of Health-sponsored PRIMARY clinical trial is led by Smidt Heart Institute cardiologist and Chair of the Department of Cardiology Christine Albert, MD, MPH. Patients come to us from all over the U.S. We treat the most complex patient cases. and overseas for our expertise.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105